Bronchodilators Market

Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or requires prescription. Basically there are available in three forms injectable, oral and inhaled. In oral forms they come in variety such as liquids, tablets and capsules, these oral forms are delivered in higher doses which is directly absorbed into the bloodstream and so they have relatively more side effects. Whereas inhaled once are directly deposited in the lungs causing less side effects. Bronchodilators are of basically-acting or long-acting beta2-agonists and anticholinergic agents or theophylline. They function so as to control asthma and COPD. Short acting bronchodilators function for fast relief of asthma symptoms and long acting bronchodilators function for control symptoms of asthma.
Bronchodilators Market aims to provide a comprehensive presentation of the global market for Bronchodilators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bronchodilators. Bronchodilators Market contains market size and forecasts of Bronchodilators in global, including the following market information:
Global Bronchodilators Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Bronchodilators Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Bronchodilators companies in 2022 (%)
The global Bronchodilators market was valued at US$ 32040 million in 2022 and is projected to reach US$ 42720 million by 2029, at a CAGR of 4.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Increase in prevalence of pulmonary disorders, smoking, and junk food fuel the bronchodilators market growth. In addition, rise in disposable income, geriatric population, and increase in awareness of healthcare among population are anticipated to boost the market growth. However, side effects associated with bronchodilators and government regulations related to the safety & efficacy of the bronchodilators hinder the market. Ongoing R&D activities related to bronchodilators are anticipated to present new opportunities for the market.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bronchodilators manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bronchodilators Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Bronchodilators Market Segment Percentages, by Type, 2022 (%)
Anticholinergic Bronchodilators
Adrenergic Bronchodilators
Bronchodilator Combinations
Methylxanthines
Global Bronchodilators Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Bronchodilators Market Segment Percentages, by Application, 2022 (%)
Asthma
COPD
Others
Global Bronchodilators Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Bronchodilators Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bronchodilators revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Bronchodilators revenues share in global market, 2022 (%)
Key companies Bronchodilators sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Bronchodilators sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Boehringer Ingelheim
GlaxoSmithKline
F. Hoffmann-La Roche
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bronchodilators, market overview.
Chapter 2: Global Bronchodilators market size in revenue and volume.
Chapter 3: Detailed analysis of Bronchodilators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bronchodilators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Bronchodilators capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.